Peter Kolchinsky graduated from Harvard with a Ph.D. in virology in 2001. After graduation he got $4 Million from Vertex Pharma co-founder Rich Aldrich and started picking biotech stocks at RA Capital. In 2002 he broke even when the S&P 500 index lost 22%. By the end of 2003, the initial $4 Million investment became $13 Million. Boston-based RA Capital invests in companies with promising drugs and technologies.
Hedge Fund - RA Capital Management
Get Email AlertsPeter Kolchinsky Bio, Returns, AUM, Net Worth

Fund Profile
Filing Period:
Fund Name: | RA Capital Management |
Manager | Peter Kolchinsky |
Portfolio Value | $4,583,149,000 |
Change This QTR | +0.81% |
Top 13F Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
No. | Security | Ticker | Shares | Value (x$1000) | Activity | % Port | History |
---|---|---|---|---|---|---|---|
1. | ASND | 7,567,900 | $888,169 | 19.37% | |||
2. | BIIB | 727,024 | $153,111 | NEW | 3.34% | ||
3. | AVTE | 8,263,982 | $151,479 | 3.3% | |||
4. | CTKB | 13,381,054 | $144,248 | +40% | 3.14% | ||
5. | ITOS | 4,417,259 | $142,147 | 3.1% |
Latest 13D & 13G Filings
Symbol | Company | Filed By | Filing Date | Filing |
---|---|---|---|---|
2022-05-16 | ||||
2022-05-16 | ||||
2022-05-16 | ||||
2022-05-16 | ||||
2022-05-02 |
News, Interviews and Investor Letters